Angharad was awarded a BSc (Hons) in Optometry from Cardiff University in 2013 and qualified as a Member of the College of Optometrists in 2014. She is currently working towards her PhD which centres on investigating the effects of the drug ranibizumab (Lucentis) on the function and structure of the peripheral retina in people with neovascular Age-Related Macular Degeneration.
BSc (Hons) Optometry, Cardiff University, 2013
Faculty Member, The Vision Care Institute, 2014 - present
Locum Optometrist, Cwm Taf area, 2014 - present
Optometrist, Davies and Jones Optometrists, 2013 - 2014 (pre-registration period August 2013 - July 2014)
Member of the College of Optometrists
Member of the Association of Optometrists
Registered with the General Optical Council
'Leader of the Future', Optician Awards, 2014
'Student of the Year' (winner), AOP Awards 2014
'Student of the Year' (runner up), AOP Awards 2013
Angharad's PhD is titled "An Investigation of the effect of long-term anti-VEGF therapy on retinal function and structure in people with neovascular Age-Related Macular Degeneration."
The approval of the anti-VEGF agent Ranibizumab (Lucentis) by the National Institute for Health and Care Excellence in 2008 represented a change in the management of neovascular Age-Related Macular Degeneration in the UK, for the first time offering a treatment which has the potential to improve visual function in people with this devastating condition. This project will investigate the effects on the retina of the long term suppression of a growth factor which is expressed physiologically in the healthy eye.
- Taylor, D.J., Hobby, A.E., Binns, A.M. and Crabb, D.P. (2016). How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open, 6(12), pp. e011504–e011504. doi:10.1136/bmjopen-2016-011504.
APM024 Examination of Eyes